Document is current

Any future updates will be listed below

Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology

Crossref DOI link: https://doi.org/10.1007/s13277-015-3728-0

Published Online: 2015-07-07

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark